Our strategy is to leverage our expertise in organocatalysis to design and develop robust, scalable, green processes to make high-value advanced intermediates and API’s for well-known drugs.
Our suite of organocatalysts are cheap, selective, scalable and recyclable; and do not use expensive precious metals.
Typical process characteristics include:
No temperature or pressure extremes required
All solvents class 2 or 3
E-factor of between 10 and 15
Notable successes include our processes for advanced intermediates of the following drugs – typically yielding a 60-80% reduction in Raw Material Costs:
We also actively engage on projects with the Pharmaceutical and Fine Chemical communities to target other high value intermediates via organocatalysis.
Please contact us with any queries